Xtant Medical Hldgs Stock Gross Profit
| XMS Stock | EUR 0.34 0.01 3.03% |
XTANT MEDICAL HLDGS fundamentals help investors to digest information that contributes to XTANT MEDICAL's financial success or failures. It also enables traders to predict the movement of XTANT Stock. The fundamental analysis module provides a way to measure XTANT MEDICAL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to XTANT MEDICAL stock.
XTANT |
XTANT MEDICAL HLDGS Company Gross Profit Analysis
XTANT MEDICAL's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current XTANT MEDICAL Gross Profit | 32.49 M |
Most of XTANT MEDICAL's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, XTANT MEDICAL HLDGS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, XTANT MEDICAL HLDGS reported 32.49 M of gross profit. This is 98.55% lower than that of the Healthcare sector and 97.98% lower than that of the Medical Devices industry. The gross profit for all Germany stocks is 99.88% higher than that of the company.
XTANT Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses XTANT MEDICAL's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of XTANT MEDICAL could also be used in its relative valuation, which is a method of valuing XTANT MEDICAL by comparing valuation metrics of similar companies.XTANT MEDICAL is currently under evaluation in gross profit category among its peers.
XTANT Fundamentals
| Return On Equity | -0.26 | |||
| Return On Asset | -0.0619 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | (0.1) % | |||
| Shares Outstanding | 108.66 M | |||
| Shares Owned By Insiders | 7.59 % | |||
| Shares Owned By Institutions | 75.17 % | |||
| Revenue | 56.67 M | |||
| Gross Profit | 32.49 M | |||
| EBITDA | (4.28 M) | |||
| Net Income | (2.83 M) | |||
| Cash And Equivalents | 20.31 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 17.43 M | |||
| Debt To Equity | 0.51 % | |||
| Current Ratio | 3.83 X | |||
| Book Value Per Share | 0.32 X | |||
| Cash Flow From Operations | 1.79 M | |||
| Earnings Per Share | (0.08) X | |||
| Number Of Employees | 116 | |||
| Beta | 0.63 | |||
| Market Capitalization | 72.54 M | |||
| Z Score | 2.4 |
About XTANT MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze XTANT MEDICAL HLDGS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of XTANT MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of XTANT MEDICAL HLDGS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in XTANT Stock
XTANT MEDICAL financial ratios help investors to determine whether XTANT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in XTANT with respect to the benefits of owning XTANT MEDICAL security.